/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Dr. Turgeon’s research focuses on integrating high-quality observational studies and meta-analyses of clinical studies to guide the creation and evaluation of decision support tools and other knowledge translation strategies to ensure that pharmacotherapy for cardiovascular disease align with patient goals, preferences and values. His research is centered on implementation science, with a focus on antithrombotic agents, lipid-lowering therapies, pharmacotherapy for heart failure, and on the cardiovascular safety of medications.
